RedHill Biopharma Management
Management criteria checks 4/4
RedHill Biopharma's CEO is Dror Ben-Asher, appointed in Aug 2009, has a tenure of 15.25 years. total yearly compensation is $594.61K, comprised of 79.6% salary and 20.4% bonuses, including company stock and options. directly owns 0.031% of the company’s shares, worth $3.19K. The average tenure of the management team and the board of directors is 4.9 years and 13.5 years respectively.
Key information
Dror Ben-Asher
Chief executive officer
US$594.6k
Total compensation
CEO salary percentage | 79.6% |
CEO tenure | 15.3yrs |
CEO ownership | 0.03% |
Management average tenure | 4.9yrs |
Board average tenure | 13.5yrs |
Recent management updates
Recent updates
This Is Why RedHill Biopharma Ltd.'s (NASDAQ:RDHL) CEO Compensation Looks Appropriate
Sep 10RedHill Biopharma Ltd. (NASDAQ:RDHL) Might Not Be As Mispriced As It Looks
Jul 28One RedHill Biopharma Ltd. (NASDAQ:RDHL) Analyst Has Been Cutting Their Forecasts
Nov 24RedHill Biopharma receives Nasdaq notification regarding minimum bid price deficiency
Oct 18RedHill wins EU’s orphan drug status to RHB-204 for rare lung disease
Aug 17RedHill: Given Up For Dead
Apr 30RedHill Biopharma: Looking At An Unexciting Dead-End
Dec 30RedHill Biopharma Ltd. (NASDAQ:RDHL) Just Reported, And Analysts Assigned A US$15.79 Price Target
Dec 02CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -US$30m |
Mar 31 2024 | n/a | n/a | -US$28m |
Dec 31 2023 | US$595k | US$473k | US$24m |
Sep 30 2023 | n/a | n/a | US$34m |
Jun 30 2023 | n/a | n/a | US$12m |
Mar 31 2023 | n/a | n/a | -US$900k |
Dec 31 2022 | US$865k | US$601k | -US$72m |
Sep 30 2022 | n/a | n/a | -US$92m |
Jun 30 2022 | n/a | n/a | -US$78m |
Mar 31 2022 | n/a | n/a | -US$95m |
Dec 31 2021 | US$1m | US$717k | -US$98m |
Sep 30 2021 | n/a | n/a | -US$98m |
Jun 30 2021 | n/a | n/a | -US$95m |
Mar 31 2021 | n/a | n/a | -US$82m |
Dec 31 2020 | US$817k | US$445k | -US$76m |
Sep 30 2020 | n/a | n/a | -US$64m |
Jun 30 2020 | n/a | n/a | -US$55m |
Mar 31 2020 | n/a | n/a | -US$50m |
Dec 31 2019 | US$708k | US$355k | -US$42m |
Sep 30 2019 | n/a | n/a | -US$38m |
Jun 30 2019 | n/a | n/a | -US$39m |
Mar 31 2019 | n/a | n/a | -US$39m |
Dec 31 2018 | US$576k | US$352k | -US$39m |
Sep 30 2018 | n/a | n/a | -US$42m |
Jun 30 2018 | n/a | n/a | -US$47m |
Mar 31 2018 | n/a | n/a | -US$47m |
Dec 31 2017 | US$634k | US$336k | -US$46m |
Compensation vs Market: Dror's total compensation ($USD594.61K) is about average for companies of similar size in the US market ($USD655.65K).
Compensation vs Earnings: Dror's compensation has been consistent with company performance over the past year.
CEO
Dror Ben-Asher (58 yo)
15.3yrs
Tenure
US$594,612
Compensation
Mr. Dror Ben-Asher Co-Founded at RedHill Biopharma Ltd. and has been its Chief Executive Officer since August 3, 2009. Mr. Ben-Asher serves as an Associate of Mercator Group, LLC.He has been affiliated wi...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 15.3yrs | US$594.61k | 0.031% $ 3.2k | |
Chief Financial Officer | 1.5yrs | US$354.22k | 0.013% $ 1.4k | |
Chief Operating Officer | 8.6yrs | US$379.96k | 0.019% $ 2.0k | |
Chief Corporate & Business Development Officer | 4.1yrs | US$353.70k | 0.021% $ 2.2k | |
Chief Commercial Officer | 5.8yrs | US$469.80k | 0.0089% $ 931.1 | |
Senior Business Development & Investor Relations Manager | 4.9yrs | no data | no data | |
Senior Vice President of Research & Development | 1.3yrs | US$419.98k | 0.014% $ 1.5k | |
Chief Business Officer | 12.3yrs | US$504.63k | 0.013% $ 1.3k | |
Senior Vice President of Regulatory Affairs | 1.3yrs | no data | no data |
4.9yrs
Average Tenure
54yo
Average Age
Experienced Management: RDHL's management team is considered experienced (4.9 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 15.3yrs | US$594.61k | 0.031% $ 3.2k | |
Chief Commercial Officer | 8.8yrs | US$469.80k | 0.0089% $ 931.1 | |
Independent Director | 13.5yrs | no data | 0.0012% $ 122.4 | |
Member of Advisory Board | no data | no data | no data | |
Member of Advisory Board | 5.8yrs | no data | no data | |
Member of Advisory Board | no data | no data | no data | |
Independent Director | 5.2yrs | no data | 0.041% $ 4.2k | |
Member of Advisory Board | no data | no data | no data | |
Member of Advisory Board | no data | no data | no data | |
Independent Director | 14.5yrs | no data | 0.0095% $ 997.0 | |
Independent Director | 14.9yrs | no data | 0.061% $ 6.4k | |
Member of Advisory Board | no data | no data | no data |
13.5yrs
Average Tenure
65yo
Average Age
Experienced Board: RDHL's board of directors are seasoned and experienced ( 13.5 years average tenure).